why Esperion Therapeutics Inc. [ESPR] is a Good Choice for Investors After New Price Target of $7.59
Esperion Therapeutics Inc. [NASDAQ: ESPR] loss -0.47% on the last trading session, reaching $2.12 price per share at the time. If compared to the average trading volume of 3.89M shares, ESPR reached a trading volume of 4628154 in the most recent trading day, which is